In this retrospective cohort study, we measured cystatin C in plasma samples obtained from 919 subjects with ARDS on enrollment in the Fluid and Catheter Treatment Trial (FACTT) [9]. This evidence concerns the gene CST3 and acute respiratory distress syndrome.